Physician

Alexis J Lukach, MD

According to 2025 Medicare claims, Alexis Lukach, MD (NPI: 1497249387) practices dermatology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is YARDLEY DERMATOLOGY ASSOCIATES, P.C. (NPI: 1205120599; TIN: 274627971) and primary practice location at 19067-5515.

Lukach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 969 traditional Medicare patients, billed 4,767 HCPCS/CPT codes, and received $300,406 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,223 prescription claims across 608 beneficiaries totaling $209,822 in drug costs, led by Jublia (Efinaconazole). Open Payments data shows 63 records totaling $1,420. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,028 to $209,822. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$150K$300K2022 Medicare payment: $50,630 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $247,881 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $300,406 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022203905$50,630
20237744,063$247,881
20249694,767$300,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$105K$210K2018 Drug cost: $2,028 (USD; Tot_Drug_Cst)2019 Drug cost: $580 (USD; Tot_Drug_Cst)2022 Drug cost: $6,604 (USD; Tot_Drug_Cst)2023 Drug cost: $194,985 (USD; Tot_Drug_Cst)2024 Drug cost: $209,822 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R28$2,028
2019N/R11$580
2020N/RN/RN/R
2021N/RN/RN/R
2022105174$6,604
2023475952$194,985
20246081,223$209,822

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more221221$120
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more442669$98
17110Destruction of skin growth, 1-14 growths236286$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more316367$67
17000Destruction of precancer skin growth, 1 growth273328$39

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JubliaEfinaconazole17625$27,960
FluorouracilFluorouracil1313,800$7,144
TacrolimusTacrolimus691,989$4,632
KetoconazoleKetoconazole2376,489$3,588
Azelaic AcidAzelaic Acid411,150$3,145

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.63$1,420Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexis J. Lukach, MD?

Tedicare shows public-source Medicare data for Alexis J. Lukach, MD (NPI 1497249387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexis J. Lukach, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexis J. Lukach, MD?

Alexis J. Lukach, MD is linked to YARDLEY DERMATOLOGY ASSOCIATES, P.C. (billing NPI 1205120599) in the available physician profile data.

Does Alexis J. Lukach, MD have Open Payments data?

Alexis J. Lukach, MD has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.